Tandem Diabetes Care (TNDM) Cash from Investing Activities (QoQ) (2013 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Cash from Investing Activities (QoQ) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.31% |
| Mar 31, 2026 | -1,205.07% |
| Dec 31, 2025 | -172.93% |
| Sep 30, 2025 | -64.67% |
| Jun 30, 2025 | 532.81% |
| Mar 31, 2025 | 83.35% |
| Dec 31, 2024 | 125.18% |
| Sep 30, 2024 | -462.03% |
| Jun 30, 2024 | 29.98% |
| Mar 31, 2024 | 69.51% |
| Dec 31, 2023 | 65.82% |
| Sep 30, 2023 | -951.61% |
| Jun 30, 2023 | 121.64% |
| Mar 31, 2023 | -173.59% |
| Dec 31, 2022 | 352.61% |
| Sep 30, 2022 | -322.79% |
| Jun 30, 2022 | 22.32% |
| Mar 31, 2022 | 106.77% |
| Dec 31, 2021 | -95.95% |
| Sep 30, 2021 | 39.47% |